Glaxo Reaches $2.2 Billion Dementia Drug Deal With Alector

(Bloomberg) — GlaxoSmithKline Plc agreed to fork out U.S. biotech Alector Inc. as a great deal as $2.2 billion to acquire therapies focusing on disorders this sort of as Parkinson’s…

She Bought a Truck on eBay, Then Forgot It. A Dementia Diagnosis Came Later.

“We went into the study contemplating we may well be ready to see these financial indicators,” said Lauren Hersch Nicholas, a co-author of the examine who is an associate professor…